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RESEARCH ARTICLE
Avian yolk androgens are metabolized rather than taken up by
the embryo during the first days of incubation
Neeraj Kumar1,4,*, Annie van Dam2, Hjalmar Permentier2, Martijn van Faassen3, Ido Kema3, Manfred Gahr4
and Ton G. G. Groothuis1
ABSTRACT
Several studies show effects of yolk androgens in avian eggs on the
phenotype of the offspring. Yolk hormone concentrations decline
strongly within the first few days of incubation. Although early
embryonic uptake of yolk androgens is suggested by the presence
of radioactivity in the embryo when eggs are injected with
radiolabelled androgens, these studies do not verify the chemical
identity of radioactive compound(s), although it is known that these
androgens can bemetabolized substantially. By using stable isotope-
labelled testosterone and androstenedione in combination with mass
spectrometry, enabling verification of the exact molecular identity of
labelled compounds in the embryo, we found that after 5 days of
incubation the androgens were not taken up by the embryo. However,
their concentrations in the entire yolk albumen homogenates declined
strongly, even when corrected for dilution by albumen and water. Our
results indicate metabolism of maternal androgens, very likely to 5β-
androstane-3α,17β-diol, etiocholanolone and their conjugated forms.
The results imply that the effects of increased exposure of the embryo
to maternal androgens take place either before this early conversion
or are mediated by these metabolites with an as yet unknown
function, opening newavenues for understanding hormone-mediated
maternal effects in vertebrates.
KEYWORDS: Maternal effects, Early hormone conversion, Prenatal,
Birds, Egg incubation, Embryonic hormone uptake
INTRODUCTION
Exposure of the vertebrate embryo to maternal hormones can have
long-lasting effects on offspring morphology, physiology and
behaviour in a wide array of taxa, including fish (Brown et al., 2014;
Guiguen et al., 2010; Pri-Tal et al., 2011), reptiles (Clairardin et al.,
2013; Paitz and Bowden, 2011; Radder, 2007), birds (Gil, 2008;
Schwabl, 1993; von Engelhardt and Groothuis, 2011) and mammals
(Del Giudice, 2012; Drea, 2011; Harris and Seckl, 2011). In egg-
laying vertebrate species, such as birds, almost the entirety of
embryonic development occurs outside the mother’s body,
facilitating measurement and manipulation of this prenatal
hormonal exposure. Steroid hormone deposition by the avian
mother into her eggs varies with environmental cues (Eising et al.,
2001; Gil, 2008; Hahn, 2011; Müller et al., 2002; Schwabl, 1993,
1997; von Engelhardt and Groothuis, 2011; Welty et al., 2012).
Hormone manipulation of avian eggs revealed a wide array of
phenotypic effects on the offspring, including traits such as hatching
time, hatching success, metabolic rate, immune function, endocrine
function, growth, competitiveness, reproduction, mate choice and
survival rate (von Engelhardt and Groothuis, 2011). It is generally
thought that these hormone-mediated maternal effects are adaptive,
providing a maternal ‘weather forecast’ for the chick to adjust its
phenotype to the environment that it will experience after hatching
(Groothuis et al., 2005). However, despite the many descriptive and
functional studies in this field, underlying mechanisms of how and
when the embryo is able to react to the maternal hormones are still
not known. This hampers progress in the research field (Carere and
Balthazart, 2007; Groothuis and Schwabl, 2008), for example, in
understanding the role of the offspring in family conflict (Müller
et al., 2007).
In order to be functional, these maternal egg hormones must reach
the offspring’s tissues, but whether this is indeed the case is not yet
clear. Several studies indicate a strong decrease of yolk hormone
concentrations within the first few days of egg incubation (Bowden
et al., 2002; Eising et al., 2003; Elf and Fivizzani, 2002; Feist and
Schreck, 1996; Paitz and Bowden, 2009; Wilson and McNabb,
1997) and one study showed that this is not due to mixing of yolk
with albumen (Paitz et al., 2011), raising the question as to whether
this is due to embryonic uptake or metabolism, and to what extent
and which metabolites really reach the embryo. One explanation for
the decrease in androgens and estrogens during early incubation is
that conjugation of active steroids takes place, facilitating uptake of
these hormones from the lipophilic environment (the yolk), after
which the embryo may deconjugate the hormone when and where it
is required (Paitz and Bowden, 2008, 2013).
Additional complexity is added by the fact that a steroid of
interest found in embryonic tissue might not be of maternal origin
but could be synthesized de novo by the embryo itself. Such de novo
synthesis may be due to the activity of maternal or embryonic
enzymes in the egg using maternal steroids and/or cholesterol in the
yolk as a substrate (Bruggeman et al., 2002; Nomura et al., 1999).
Therefore, any steroids detected in the embryonic tissues even in
early development could be derived de novo from precursors. In
order to resolve this problem, radioactive steroids have been injected
into egg yolk, followed by detection of radioactivity in the
embryonic tissues (Benowitz-Fredericks and Hodge, 2013; von
Engelhardt et al., 2009). However, these studies could only detect
radioactivity originating from the labelled hormones in embryonic
tissues and did not verify the molecular identity of the radiolabelled
compound. A few other studies analysing steroid metabolism in
incubated eggs suggested that maternal steroids were metabolized
and conjugated (Paitz et al., 2011, 2012; Vassallo et al., 2014). This
indicates that radioactive compound(s) in the embryonic tissueReceived 5 October 2018; Accepted 5 March 2019
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could have been a different metabolite, or even a biologically
inactive form of it, rather than the originally injected steroid.
In order to study early hormone metabolism and embryonic
uptake, and to differentiate maternal from other newly synthesized
compounds, we injected a stable isotope labelled form of the most
frequently studied steroid in this field, testosterone ([2H3]T), and its
precursor androstenedione ([13C3]A4), into chicken egg yolk and
incubated the eggs for either zero or 5 days. The advantage of using
stable isotope labels is that the metabolic outcome can be tracked
using liquid chromatography combined with tandem mass
spectrometry (LC-MS/MS), a method that is very accurate for
molecular identification and can distinguish between naturally
occurring and the heavy isotope labelled compounds that differ only
with respect to their mass. The incubation time of 5 days was chosen
because the gonadal differentiation (Smith et al., 1997; Yoshida
et al., 1996) and the surge of the endogenous steroid production
(Woods et al., 1975) in chicken embryos starts only after 5 days of
egg incubation. The injected hormone values were within two
standard deviations of the mean yolk hormone concentrations
(T=0.74±0.13 pg mg−1; A4=23.24±2.20 pg mg−1; means±s.d.)
obtained by mass spectrometry in unincubated eggs (day 0) laid on
the same day.
We characterized the in ovo dynamics of the labelled T and A4
over the first 5 days both in the yolk albumen homogenate and in the
embryo, separating the embryo itself and its extra-embryonic
membranes, including the yolk sac membrane, where the uptake of
yolk and its hormones to the circulation of the embryo is likely to
take place. The chicken embryo expresses the steroidogenic genes
P-450scc, 3β-HSD, P-450c17 and 17β-HSD, but not aromatase
(Nomura et al., 1999) before day 5, which is necessary to convert
androgens into estrogens, so we investigated only the androgen
pathways. The majority of maternal hormones are deposited in the
yolk, but the yolk becomes mixed with albumen early during
incubation. Therefore, the decline in yolk hormone concentrations
reported in the literature (Bowden et al., 2002; Eising et al., 2003;
Elf and Fivizzani, 2002; Feist and Schreck, 1996; Paitz and
Bowden, 2009; Wilson and McNabb, 1997) might be due not to
metabolism but rather to the dilution of yolk, for which no evidence
was found in European starling (Paitz et al., 2011) and rock pigeon
(Kumar et al., 2018a) eggs, but is as yet unknown for chicken eggs.
Therefore, we performed this study in the yolk albumen
homogenate, enabling us to distinguish between both hypotheses.




This study used 5-day-old chicken embryos and thus does not require
an ethical license or approval from an animal experimentation
committee.
Experimental design
Fertile chicken eggs of Lohman Brown Classic strain [Gallus gallus
domesticus (Linnaeus 1758)] were randomly collected from a local
chicken farm. Eggs were randomly assigned to three weight-
matched groups and incubated for 5 days at 37°C with relative
humidity of 60%, either untreated or after injecting 100 µl of
sterilized sesame oil with 0.2 µg ml−1 [2H3]T or 0.58 µg ml−1
[13C3]A4 into the yolk, following the same procedure as in our
previous study (von Engelhardt et al., 2009). These concentrations
were within the physiological range (two times standard deviations)
of the naturally present (unlabelled) T and A4 levels, which were
determined using 200 mg homogenates of yolk plus albumen from
unincubated eggs of the same batch. Although injection into the
yolk at one particular spot may not adequately represent the
distribution of maternal hormones over the different yolk layers,
these layer structures quickly disappear after a few days of
incubation. Moreover, most studies inject hormones dissolved in
oil into the yolk as we did, so we can directly compare our findings
with these studies. To determine the concentrations of labelled
hormones, each treated egg was separated into three fractions: yolk
albumen, decapitated embryo (embryo heads were used for
determination of steroid receptor expression as part of another
study) and extra-embryonic membranes. Each fraction was
homogenized separately and used for hormone extractions.
Labelled hormones were extracted from 200 mg homogenates of
yolk plus albumen of unincubated [day (d)0, n=3] and incubated
(d5, n=3) eggs, individual decapitated embryos (E, n=3) and
200 mg of extra-embryonic membranes (EM, n=3) for each
treatment. Because of small sample sizes (n=3), no statistical tests
were performed. To convert conjugated steroids to their free forms,
single extracts were hydrolysed from 200 mg of yolk albumen
homogenate of incubated eggs, 100 mg of decapitated embryo
homogenates and 200 mg of extra-embryonic membranes for each
treatment. To exclude the possibility that the lack of labelled
androgens in the decapitated embryonic tissues could be due to
decapitation itself, T and A4 concentrations were determined using
eggs from the same batch and the same analytical technique over the
same time period for intact embryos (head plus the rest of the body)
using 100 or 300 mg homogenates.
Extraction of steroids
Each sample was extracted twice in 1 ml methanol by vortexing,
followed by centrifugation at 12,000 g for 10 min at room
temperature. The supernatant was transferred to tubes containing
200 mg solid ZnCl2 for lipid precipitation (Wang et al., 2010). The
total volume of the combined supernatants was made to 4 ml by
adding 2 ml methanol, and centrifuged at 12,000 g for 10 min at
4°C. The supernatant was dried under nitrogen gas in a waterbath at
50°C, resuspended in 1 ml methanol, centrifuged at 12,000 g for
10 min at room temperature, followed by addition of 1.8 ml water to
the supernatant. This mixturewas centrifuged at 12,000 g for 10 min
at 4°C. The supernatant was loaded on C18 SPE columns (3 ml,
500 mg, Grace Inc.) pre-equilibrated with 3 ml methanol, followed
by 3 ml water. After collecting flow through, the column was
washed with 3 ml water, and then eluted with 2 ml methanol. The
average recovery for extraction was 85.1±4.3% (mean±s.d.) as
measured for testosterone.
The conjugated steroid levels can be estimated as the difference
between hydrolysed and non-hydrolysed extracts from the same
samples as the hydrolysis converts a conjugated steroid into its free
form (e.g. Mi et al., 2014). For hydrolysis of conjugates, the extract
was dried under vacuum and resuspended in 2 ml acetate buffer
(0.5 mol l−1 sodium acetate with 15 g l−1 sodium ascorbate,
pH 4.8). A volume of 100 µl of commercial extract of Helix
pomatia (Suc d’Helix Pomatia, Brunschwig Chemie) was added,
vortexed and incubated at 46°C for 2 h. The hydrolysed sample was
cooled at room temperature and purified on HLB SPE columns
(3 ml, Waters Inc.) pre-equilibrated with 2 ml methanol, followed
by 2 ml water. After collecting flow through, the column was
washed with 2 ml water, and then eluted with 2 ml methanol. The
eluent was dried under vacuum, resuspended in 150 µl methanol,
followed by addition of 350 µl water to make a final concentration of
30% methanol, and was analysed by mass spectrometry.
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The extracts were analysed by LC-MS/MS using the following two
approaches. Firstly, HPLC was performed using a Shimadzu LC
system, consisting of a SIL-20AC autosampler and two LC-20AD
gradient pumps. Chromatographic separation was achieved at 30°C
on an Alltima C18 column (2.1×150 mm 5 µm, Grace Davison
Discovery Sciences). Eluent A was 100% H2O and eluent B was
100% methanol without formic acid. The elution was performed
starting at 10% B, followed by a linear gradient to 80% B in 2 min
followed by a linear gradient to 95% B in 3 min. Then, the column
was washed at 95% B for 7 min after which it was returned to the
starting conditions. The flow ratewas 0.25 ml min−1 and the injection
volume was 30 µl. The HPLC system was coupled to an API 3000
triple-quadrupole mass spectrometer (Applied Biosystems/MDS
Sciex). For positive ionization, the mass spectrometer was
equipped with an atmospheric pressure chemical ionization (APCI)
source. For negative ionization, a TurboIonSpray electrospray
ionization (ESI) source was coupled to the mass spectrometer and a
1% ammonia solution in 50% methanol was introduced post-column
with a flow rate of 0.05 ml min−1. The source temperature was
450°C. Nitrogen was used as turbo heater gas, nebulizer gas and
curtain gas. Tuning parameters were optimized for the selected
reaction monitoring (SRM) ion pairs of the steroids for which
standards were available. For the isotopically labelled compounds
SRM ion pairs were calculated (see Table S1). For each compound,
two SRM ion pairs were determined, where the most intense was
selected as quantifier while the other served as qualifier. For
quantification of the isotopically labelled compounds the standard
addition method was applied using the non-labelled forms of the
compounds. Data were collected and analysed with Analyst 1.5.2
software (Applied Biosystems/MDS Sciex).
In the second method, 25 µl of 13C3 labelled 17-
hydroxyprogesterone (30 nmol l−1 in 50% methanol, IsoSciences)
was added to each extract as an internal standard and analysed with a
XEVO TQ-S tandem mass spectrometer (Waters Corp.), equipped
with an Online SPE Manager and ACQUITY UPLC system (Waters
Corp.). The UPLC flow rate was set at 0.4 ml min−1 using
10 mmol l−1 ammonium acetate, 0.1% formic acid in water and
methanol (containing 0.1% formic acid) as mobile phases A and B
respectively. For each extract, 40 µl samplewas injected for extraction
on a XBridge C8 cartridge and chromatographic separation was
performed on a Kinetex C18 column (2.1×100 mm, 2.6 µm). The
mass spectrometer was operated under electrospray ionization mode
with following operating conditions: cone voltage of 30 V,
desolvation temperature of 600°C and source temperature of
150°C, collision energy of 15–40 eV optimized for different
analytes. Quantitative calibration was performed by using a
calibration curve using the internal standards for each analyte. The
analysis was performed by monitoring two mass transitions for each
analyte. The multiple reaction monitoring (MRM) transitions (m/z)
are shown in the Table S2. The quantification limit was 0.01 pg mg−1
of yolk or embryonic tissues for A4 and T; and 0.02 pg mg−1 for
dihydrotestosterone (DHT).
RESULTS
Naturally occurring (unlabelled) T, 5α- or 5β-DHT, or their
conjugated forms were not detectable in the intact chicken
embryo (head plus rest of the body, excluding extra-embryonic
membranes) after 5 days of egg incubation, and A4 was present at an
extremely low concentration of 0.02 pg mg−1. The levels of injected
[2H3]T (Fig. 1A) and [13C3]A4 (Fig. 1B) declined strongly in the
yolk albumen homogenates during the first 5 days of incubation.
Labelled Twas no longer detectable after 5 days of incubation in the
yolk albumen homogenate, extra-embryonic membranes or the
embryo itself (Fig. 1A). Labelled A4 was present in only very low
concentrations and only in the yolk albumen homogenate after 5
days (Fig. 1B). Moreover, no labelled forms of DHT (one of the two
biologically active metabolites of T), conjugated T or conjugated
DHT were detectable in any egg fraction.
DISCUSSION
We found a lack of labelled T in all three egg fractions, and of labelled
A4 in embryonic fractions, after 5 days of incubation. The use
of internal standards and sample purification during extraction
procedures using ZnCl2 and solid phase extraction columns ensured
that the lack of labelled compounds in embryonic fractions could not
be due to matrix effect (affecting differences in ionization efficiency
in the mass spectrometer among samples from different tissues). If
there was an uptake of even 10% of the injected labelled hormones
by the embryo, as suggested in previous studies based on the
radioactivity transfer to embryonic chicken tissues (Benowitz-
Fredericks and Hodge, 2013; von Engelhardt et al., 2009), we
would expect about 10 pg mg−1 [2H3]T and 50 pg mg
−1 [13C3]A4 in
the embryonic fractions based on embryonic weight. However, after
5 days of incubation, no labelled T or A4 was found at all, despite
quantification limits as low as 0.01 pg mg−1. This indicates that in the
previous studies, the labelled signal in embryonic tissue may either be
due to conversion of injected androgens to other metabolites or may
not have been from steroid hormones at all if the radioactive label































Fig. 1. Concentration dynamics of injected stable isotope labelled [2H3]T and [13C3]A4 in fertilized chicken eggs. (A) [2H3]T and (B) [13C3]A4
concentrations assessed in yolk-albumen homogenates at day 0 (d0), day 5 (d5), in decapitated embryos (E) and in extra-embryonic membranes (EM). Values
are means±s.e.m. of sample size of three per group. Labelled forms of DHT, conjugated T and conjugated DHTwere not detectable in any fraction. Raw data are
available in Table S3.
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Since the decline of androgen concentrations was found
throughout the egg, it cannot be due to dilution with albumen or
water, or embryonic uptake. This indicates that the maternal T and
A4 are metabolized by embryonic and/or maternal enzymes, which
is in line with the suggestions made in other studies (Gilbert et al.,
2007; Kumar et al., 2018a; Paitz et al., 2011; Parsons, 1970;
Vassallo et al., 2014), as explained below. This raises the intriguing
question as to which metabolic products these androgens are
converted into, as this will determine the biological significance of
maternal hormone deposition. Since the concentrations of both
labelled T and A4 declined, interconversion of these two androgens
cannot explain their decrease. Furthermore, neither of these steroids
was converted to DHT, the androgen with the highest affinity for
androgen receptor (Fang, 2003) among the naturally occurring
androgens, or the biologically inactive conjugated forms of T and
DHT. Although our sample sizes were low (we were not aiming at
quantitative differences between groups, but only at the verification
of the uptake of injected yolk androgens by the embryo), such
sample sizes have been used convincingly in other studies
(Benowitz-Fredericks and Hodge, 2013; von Engelhardt et al.,
2009), and our results were very consistent within each group.
Although Benowitz-Fredericks and Hodge (2013) indicated
conjugation of A4, A4 cannot be directly conjugated due to lack
of a hydroxyl group, suggesting that it must have been conjugation
of a metabolite of A4 in their study. It is noteworthy that DHT,
which is often reported to be present in the yolk at day 0 in studies
using radioimmunoassays (e.g. Elf and Fivizzani, 2002; Schwabl,
1997), was not even detectable using mass spectrometry at day 0 or
day 5, in spite of its very low limit of quantification (0.02 pg mg−1),
warranting some caution for the reliability of classical
radioimmunoassays for hormone analyses of eggs.
Androgens are unlikely to be aromatized into estrogens (Fig. 2) at
such an early stage of embryonic development as aromatase is
expressed only after day 5 of incubation in chicken (Nomura et al.,
1999), which is also experimentally supported by the lack of such
early androgen conversion to estrogens (Parsons, 1970). Parsons
(1970) suggested 5β-androstane-3α,17β-diol as the main metabolite
in an in vitro study on metabolism of radiolabelled T by the 2-day-
old chicken embryo; Paitz et al. (2011) suggested conjugated
etiocholanolone as the main metabolite in the yolk albumen
homogenates of European starling eggs incubated for 6 days; and
Kumar et al. (2018a) showed etiocholanolone and its conjugate as
main androgenic metabolites in rock pigeon eggs incubated
for 4.5 days. These studies indicate a 5β-reduction, followed by
3α-hydroxylation metabolic route for maternal T and A4 (Fig. 2).
Considering the available information from above and based on
the known metabolic pathways of functionally relevant androgens
(Fig. 2), the following picture emerges: early in incubation, the
maternal and/or embryonic enzymes are already metabolizing yolk
T and A4 into 5β-androstane-3α, 17β-diol and/or etiocholanolone,
and their conjugated forms.
The functional aspects of this metabolism are intriguing and
create a paradox. Despite the well-documented effects of avian yolk
hormones on the embryo, chick and adult, the above-mentioned
metabolites are thought to be biologically inactive. Both
5β-androstane-3α,17β-diol and etiocholanolone are androgens
with very weak binding affinity to the rat androgen receptor
(Fang, 2003). A high degree of sequence similarity in the ligand-
binding domain of the mammalian and chicken androgen receptor
(Katoh et al., 2006) suggests that these metabolites would not
activate the chicken receptors. Conjugated androgens are thought to
have no biological effect as they do not bind to androgen receptors
but may rather be a way to inactivate the active forms. There are two
ways to resolve this paradox. First, it has been argued that 5β-
androstane-3α,17β-diol and etiocholanolone may act independently
of binding to androgen receptors and contribute to erythropoiesis
(Paitz et al., 2011). This may explain the wide diversity of yolk
androgen effects, as such a process may influence many
developmental processes. Second, the conjugated metabolites may
be de-conjugated back to their free forms of these metabolites in
embryonic tissues, for which some evidence was found for
conjugated estrogen in the turtle egg (Paitz and Bowden, 2011).
Both possibilities are open for experimental testing.
Recent studies on rock pigeon found no evidence for the
contribution of maternal yolk enzymes to early steroid metabolism
(Kumar et al., 2018a,b), but there could perhaps be maternal
enzymes in other egg components that contribute to some extent to

















Fig. 2. Suggested metabolic pathways for maternal T and A4 in the avian egg during early incubation. Double arrows represent reversible pathways and
single arrows represent irreversible pathways, implying that the metabolites cannot be converted back to primary androgens during later stages of embryonic
development. The pathways with interconversion between A4 and T, conversion of T into DHT, and conjugation of T and DHT were undetectable in
the present study; whereas conversion to estrogens is very unlikely due to a lack of expression of the aromatase gene. All these non-detectable or improbable
pathways are marked with a large cross. Key to steroidogenic enzymes: 1a, 5α-reductase; 1b, 5β-reductase; 2, 3α-hydroxysteroid dehydrogenase (HSD); 3,
sulfotransferase/glucuronosyltransferase; 4, sulfatase/glucuronidase; 5, 17β-HSD; 6, aromatase.
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maternal or embryonic origin, these could be an evolutionary
adaptation to use maternal hormones prior to development of the
embryonic endocrine systems at the optimal time and amount
needed for the embryo itself, and/or to avoid detrimental effects of
the relatively high yolk hormone concentrations (Groothuis and
Schwabl, 2002), as also suggested by Vassallo et al. (2014) for the
stress hormone regulation in later developmental stages. If the
enzymes are of maternal origin, this would open the possibility that
it reflects a maternal strategy by which the mother deposits different
amounts of metabolizing enzymes depending on the environmental
context. If the enzymes are of embryonic origin, it may reflect the
evolutionary arms race between mother and offspring, as maternal
hormone deposition may not always be advantageous to the chick
(Groothuis et al., 2005; Müller et al., 2007).
In conclusion, we have shown that when injected within a
physiological range, the elevated yolk androgens (T and A4) are not
taken up by the embryo but rather metabolized very early during
incubation. It remains to be explored further whether the elevated
androgen levels, before their depletion, could still exert any
physiological effect on embryonic development, for instance via
receptor-mediated regulation of gene expression or by directly
intercalating with DNA. If not, that would suggest that embryos have
evolved the capacity tometabolizematernal hormones into biologically
inactive or less-potent metabolites, so that they can buffer their
developing endocrine system against any detrimental consequences of
such early exposure to maternal hormones, potentially playing a role in
parent–offspring conflict. Alternatively, the metabolites themselves
could be functional; a possibility that needs further exploration by
simply injecting eggswith thesemetabolites and assessing their effects.
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